Valve Disease Clinical Trials
ACURATE NEO II
The purpose of this study is to evaluate safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcatheter aortic valve replacement (TAVR) in subjects with severe native aortic stenosis who are indicated for TAVR.
Sub-Investigator: Peter Mason, MD
Primary Study Coordinator: Shelley Schultz, CRC III
Status: Currently enrolling
Sub-Category: Valve Disease
ClinicalTrials.gov Identifier: NCT03735667
Meet Our Team
CLASP IITR Pivotal Clinical Trial
The objectives of this pivotal clinical trial are to evaluate the safety and effectiveness of the PASCAL System for transcatheter tricuspid valve repair with OMT compared to OMT alone in the treatment of patients with symptomatic severe tricuspid regurgitation.
Primary Sub-Investigator: Saif Anwaruddin, MD
Primary Study Coordinator: Barb Shimada-Krouwer, RN
Status: Currently enrolling
Sub-Category: Valve Disease
ClinicalTrials.gov Identifier: NCT04097145